Awareness about possible reactivation of HBsAg-negative patients when prescribing biological therapy.
Navarro
R
R
Ibañes
S
S
Llamas
M
M
Sotomayor
E
E
García-Martín
P
P
Daudén
E
E
D000998:Antiviral Agents / Q000627:therapeutic use; D001364:Awareness; D001691:Biological Therapy / Q000009:adverse effects*; D004279:DNA, Viral / Q000097:blood; D006509:Hepatitis B / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D011565:Psoriasis / Q000097:blood / Q000188:drug therapy* / Q000276:immunology
D000998:Antiviral Agents; D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens